Technical Analysis for CYTH - Cyclo Therapeutics, Inc.

Grade Last Price % Change Price Change
D 1.60 -3.03% -0.05
CYTH closed down 3.03 percent on Monday, March 18, 2024, on 2.15 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. It ran into resistance at its 50 day moving average.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
200 DMA Support Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Calm After Storm Range Contraction 0.00%
Wide Range Bar Range Expansion 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Earnings Movers Other 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Gapped Down Weakness 0.00%

   Recent Intraday Alerts

Alert Time
Gap Down Closed about 15 hours ago
Reversed from Down about 15 hours ago
Rose Above 20 DMA about 15 hours ago
10 DMA Support about 15 hours ago
60 Minute Opening Range Breakout about 15 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C and Alzheimer’s Disease. The company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is the subject of three ongoing formal clinical trials for Niemann-Pick Disease Type C, a rare and fatal genetic disease. The company is planning an early phase clinical trial using Trappsol Cyclo intravenously in Alzheimer’s Disease based on encouraging data from an Expanded Access program for late-onset Alzheimer’s Disease. Additional indications for the active ingredient in Trappsol Cyclo are in development.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Clinical Medicine Rare Diseases Alzheimer's Disease Lipid Storage Disorders

Is CYTH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.57
52 Week Low 0.67
Average Volume 109,727
200-Day Moving Average 1.52
50-Day Moving Average 1.69
20-Day Moving Average 1.66
10-Day Moving Average 1.63
Average True Range 0.15
RSI (14) 45.65
ADX 10.94
+DI 12.99
-DI 23.54
Chandelier Exit (Long, 3 ATRs) 1.46
Chandelier Exit (Short, 3 ATRs) 1.86
Upper Bollinger Bands 1.76
Lower Bollinger Band 1.55
Percent B (%b) 0.23
BandWidth 12.39
MACD Line -0.02
MACD Signal Line -0.02
MACD Histogram -0.0061
Fundamentals Value
Market Cap 45.75 Million
Num Shares 28.6 Million
EPS -1.59
Price-to-Earnings (P/E) Ratio -1.01
Price-to-Sales 51.42
Price-to-Book 1.89
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.07
Resistance 3 (R3) 2.05 1.88 1.99
Resistance 2 (R2) 1.88 1.76 1.89 1.96
Resistance 1 (R1) 1.74 1.69 1.81 1.76 1.94
Pivot Point 1.57 1.57 1.61 1.58 1.57
Support 1 (S1) 1.43 1.45 1.50 1.45 1.26
Support 2 (S2) 1.26 1.38 1.27 1.24
Support 3 (S3) 1.12 1.26 1.21
Support 4 (S4) 1.14